Author

Yanshu Cai

University of OxfordORCID 0009-0008-6814-5384Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Isabela Pedroza‐PachecoiD· 2 shared Silvia PanettiiD· 2 shared Vinnycius Pereira AlmeidaiD· 2 shared Adrian V. S. HilliD· 1 shared Amanda WickiiD· 1 shared Amit GroveriD· 1 shared Ashwin JainarayananiD· 1 shared Audrey GérardiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Isabela Pedroza‐PachecoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyCancer CellPeer-reviewedOct 1, 2026

Chemotherapy synergizes with cancer vaccines and expands stem-like TCF1+CD8+ T cells

Laurine Noblecourt, Amanda Wicki, Ashwin Jainarayanan…·Carol Sze Ki Leung

This study shows that chemotherapy, specifically CarboTaxol, synergizes with cancer vaccines and anti-PD-1 to improve tumor control and survival by expanding stem-like TCF1+CD8+ T cells.

2 citations

mouseCITE-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintJan 2, 2026

TMEM33 deletion potentiates anti-tumor CD8+ T cell immunity

Matthew P. Jackson, T. Zhao, Gusztav Milotay…·Eileen E. Parkes

This study shows TMEM33 limits progenitor-exhausted CD8+ T cells, enhances anti-tumor responses, and correlates with improved survival in melanoma patients.

DOI 10.64898/2026.01.01.697288

mousebulk RNA-seq

𝕏 PostBluesky